News By Tag
News By Location
The FemCap Cervical Cap Moves Up a Gear in Europe
RDO Medical is pleased to announce a new enhanced distribution contract for the cervical cap, FemCap, taking this key contraceptive device to the women who need it.
FemCap has been following it's development curve steadily and is now the only cervical cap actively marketed in the USA where it is FDA approved. In parallel it has been approved and distributed by the NHS in the UK through their Family Planning Clinics for many years. Furthermore the FemCap is also now recognised in Europe with the CE 0050 mark but it's in Spain and Latin America where RDO Medical will be taking the device to fresh pastures.
Valeria Arévalo, director of RDO Medical in Spain highlights the suitability of FemCap for the Spanish speaking market, "In Spain it's the pill or nothing. Diaphragms and spermicides are not widely distributed by the health services and fertility monitors, whilst very good, are beyond the financial reach of a huge section of the female community in Spain where their buying power is a lot less than other European countries." Focusing on cost and accessibility she continues, "The FemCap is cost efficient over time, more environmentally friendly than hormonal pills or condoms and most importantly it puts safe reliable contraception within the reach of more women. By designing the Spanish language website as a pre-cursor to a marketing campaign and by producing materials and packaging in Spanish too we aim to bring about new awareness and make new inroads for FemCap in the Spanish and Latin American markets."
This newly enhanced relationship is another example of RDO Medical's dedication to becoming a key point of reference in the supply and marketing of fertility and contraceptive products at all levels on a global scale.
More information can be found online at http://buyfemcap.com
# # #
RDO Medical UK Ltd is a specialist in providing natural family planning and natural fertility solutions to women and couples around the world. We supply at a personal level to the end patient as well as wholesale to distributors and health authorities.